Catalyst

Slingshot members are tracking this event:

Top-Line Phase 2 CARRIE Data Evaluating MM-141 in Front Line Pancreatic Cancer Due H2 2018 - Discontinued

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MACK

33%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Mm-141, Pancreatic Cancer, Discontinued, Discontinuation